Treating tinea cruris with satt e barg panwad.
- Conditions
- Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecified
- Registration Number
- CTRI/2024/08/071845
- Lead Sponsor
- shiba fathima
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Patient diagnosed with tinea cruris (skin of the genitals, inner thighs and buttocks) clinically
as well as by KOH mount test without nail and scalp involvement.
Patient not taking any other drugs for tinea cruris.
Patient who are willing and able to provide informed consent.
Patient who are willing and able to understand and follow the protocol for the duration of the
study.
1. Presence of complications such as secondary bacterial infection of the lesions.
2. Patients of tinea at other parts of body except tinea cruris.
3. Patients already on topical and/or systemic antifungal treatment (1 week of topical therapy and/or 4 weeks of systemic antifungal therapy before baseline visit)
4. patients with uncontrolled diabetes.
5. Immunosuppressant patients like AIDS/HIV infection.
6. pregnant and lactating women.
7. Noncompliance with the trial protocol.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Change in Investigator’s global assessment(IGA) <br/ ><br>2. Mycological cure: Clinically suspected cases of tinea cruris will be confirmed by skin scraping and KOH preparation, by visualizing presence or absence of long, narrow, septate and branching hyphae under microscope at baseline and at the conclusion of trial.Timepoint: at the baseline and at 6 week
- Secondary Outcome Measures
Name Time Method 1. Change in TCS (Total clinical score. <br/ ><br>2. Changes in Dermatology Life Quality Index.Timepoint: at the end of treatment